TEIPP-01

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTEIPP-01

Drug Alias NameTEIPP-01

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAccuro Immunology AB

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAccuro Immunology AB

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A